世界のセファロスポリン市場:成長動向・競争分析2020-2026

【英語タイトル】Global Cephalosporin Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

QYResearchが出版した調査資料(QYR20AP00506)・商品コード:QYR20AP00506
・発行会社(調査会社):QYResearch
・発行日:2020年3月20日(※2024年版があります。お問い合わせください)
・ページ数:135
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当リサーチレポートでは、セファロスポリンの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、セファロスポリンのグローバル市場動向、メーカー別競争状況、種類別市場規模(第一世代、第二世代、第三世代、第四世代)、用途別市場規模(経口、注射)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・セファロスポリンの種類別市場2015-2026:第一世代、第二世代、第三世代、第四世代
・セファロスポリンの用途別市場2015-2026:経口、注射
・セファロスポリンの北米市場分析
・セファロスポリンのアジア市場分析
・セファロスポリンの中南米市場分析
・セファロスポリンの中東・アフリカ市場分析
・関連企業情報:Union Chempharma、NCPC、Qilu Antibiotics、Lupin Pharmaceuticals、Hospira、Dhanuka Laboratories、Fukang、Dongying Pharmaceutical、Alkem、SALUBRIS、LIVZON、Hetero Drugs、CSPC、TEVA、Orchid Pharma、Taj Pharmaceuticals、Covalent Laboratories、United Laboratories、Aurobindo、Wockhardt、LKPC、HPGC、Huafangpharm
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections.The classification of Cephalosporin includes First Generation, Second Generation, Third Generation, Fourth Generation and the proportion of Third Generation in 2016 is about 37.2%, and the proportion is in increasing trend from 2012 to 2016.
In 2019, the global Cephalosporin market size was US$ 3835.6 million and is forecast to US$ 4382.3 million in 2026, growing at a CAGR of 1.9% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Cephalosporin.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Cephalosporin market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Cephalosporin market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Cephalosporin market. Readers of the report can become informed about current and future trends of the global Cephalosporin market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Cephalosporin markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Cephalosporin market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Cephalosporin market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Cephalosporin market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Cephalosporin market is segmented into
First Generation
Second Generation
Third Generation
Fourth Generation

Market Segment by Application, the Cephalosporin market is segmented into
Oral
Injection

This report includes the following manufacturers; we can also add the other companies as you want.
Union Chempharma
NCPC
Qilu Antibiotics
Lupin Pharmaceuticals
Hospira
Dhanuka Laboratories
Fukang
Dongying Pharmaceutical
Alkem
SALUBRIS
LIVZON
Hetero Drugs
CSPC
TEVA
Orchid Pharma
Taj Pharmaceuticals
Covalent Laboratories
United Laboratories
Aurobindo
Wockhardt
LKPC
HPGC
Huafangpharm

The study objectives are:
To analyze and research the global Cephalosporin status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Cephalosporin manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Cephalosporin are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Cephalosporin Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Cephalosporin Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 First Generation
1.3.3 Second Generation
1.3.4 Third Generation
1.3.5 Fourth Generation
1.4 Market Segment by Application
1.4.1 Global Cephalosporin Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Oral
1.4.3 Injection
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Cephalosporin Revenue (2015-2026)
2.1.1 Global Cephalosporin Revenue (2015-2026)
2.1.2 Global Cephalosporin Sales (2015-2026)
2.2 Cephalosporin Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Cephalosporin Sales by Regions (2015-2020)
2.2.2 Global Cephalosporin Revenue by Regions (2015-2020)
2.3 Global Top Cephalosporin Regions (Countries) Ranking by Market Size
2.4 Cephalosporin Industry Trends
2.4.1 Cephalosporin Market Top Trends
2.4.2 Market Drivers
2.4.3 Cephalosporin Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Cephalosporin Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Cephalosporin Manufacturers by Sales (2015-2020)
3.1.1 Global Cephalosporin Sales by Manufacturers (2015-2020)
3.1.2 Global Cephalosporin Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Cephalosporin Sales in 2019
3.2 Global Top Manufacturers Cephalosporin by Revenue
3.2.1 Global Cephalosporin Revenue by Manufacturers (2015-2020)
3.2.2 Global Cephalosporin Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Cephalosporin Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalosporin as of 2019)
3.4 Global Cephalosporin Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Cephalosporin Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Cephalosporin Market
3.7 Key Manufacturers Cephalosporin Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Cephalosporin Historic Market Review by Type (2015-2020)
4.1.2 Global Cephalosporin Sales Market Share by Type (2015-2020)
4.1.3 Global Cephalosporin Revenue Market Share by Type (2015-2020)
4.1.4 Cephalosporin Price by Type (2015-2020)
4.1 Global Cephalosporin Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Cephalosporin Sales Forecast by Type (2021-2026)
4.2.3 Global Cephalosporin Revenue Forecast by Type (2021-2026)
4.2.4 Cephalosporin Price Forecast by Type (2021-2026)

5 Global Cephalosporin Market Size by Application
5.1 Global Cephalosporin Historic Market Review by Application (2015-2020)
5.1.2 Global Cephalosporin Sales Market Share by Application (2015-2020)
5.1.3 Global Cephalosporin Revenue Market Share by Application (2015-2020)
5.1.4 Cephalosporin Price by Application (2015-2020)
5.2 Global Cephalosporin Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Cephalosporin Sales Forecast by Application (2021-2026)
5.2.3 Global Cephalosporin Revenue Forecast by Application (2021-2026)
5.2.4 Cephalosporin Price Forecast by Application (2021-2026)

6 North America
6.1 North America Cephalosporin Breakdown Data by Company
6.2 North America Cephalosporin Breakdown Data by Type
6.3 North America Cephalosporin Breakdown Data by Application
6.4 North America Cephalosporin Breakdown Data by Countries
6.4.1 North America Cephalosporin Sales by Countries
6.4.2 North America Cephalosporin Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Cephalosporin Breakdown Data by Company
7.2 Europe Cephalosporin Breakdown Data by Type
7.3 Europe Cephalosporin Breakdown Data by Application
7.4 Europe Cephalosporin Breakdown Data by Countries
7.4.1 Europe Cephalosporin Sales by Countries
7.4.2 Europe Cephalosporin Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Cephalosporin Breakdown Data by Company
8.2 Asia Pacific Cephalosporin Breakdown Data by Type
8.3 Asia Pacific Cephalosporin Breakdown Data by Application
8.4 Asia Pacific Cephalosporin Breakdown Data by Regions
8.4.1 Asia Pacific Cephalosporin Sales by Regions
8.4.2 Asia Pacific Cephalosporin Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Cephalosporin Breakdown Data by Company
9.2 Latin America Cephalosporin Breakdown Data by Type
9.3 Latin America Cephalosporin Breakdown Data by Application
9.4 Latin America Cephalosporin Breakdown Data by Countries
9.4.1 Latin America Cephalosporin Sales by Countries
9.4.2 Latin America Cephalosporin Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Cephalosporin Breakdown Data by Type
10.2 Middle East and Africa Cephalosporin Breakdown Data by Application
10.3 Middle East and Africa Cephalosporin Breakdown Data by Countries
10.3.1 Middle East and Africa Cephalosporin Sales by Countries
10.3.2 Middle East and Africa Cephalosporin Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Union Chempharma
11.1.1 Union Chempharma Corporation Information
11.1.2 Union Chempharma Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Union Chempharma Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Union Chempharma Cephalosporin Products and Services
11.1.5 Union Chempharma SWOT Analysis
11.1.6 Union Chempharma Recent Developments
11.2 NCPC
11.2.1 NCPC Corporation Information
11.2.2 NCPC Business Overview and Total Revenue (2019 VS 2018)
11.2.3 NCPC Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 NCPC Cephalosporin Products and Services
11.2.5 NCPC SWOT Analysis
11.2.6 NCPC Recent Developments
11.3 Qilu Antibiotics
11.3.1 Qilu Antibiotics Corporation Information
11.3.2 Qilu Antibiotics Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Qilu Antibiotics Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Qilu Antibiotics Cephalosporin Products and Services
11.3.5 Qilu Antibiotics SWOT Analysis
11.3.6 Qilu Antibiotics Recent Developments
11.4 Lupin Pharmaceuticals
11.4.1 Lupin Pharmaceuticals Corporation Information
11.4.2 Lupin Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Lupin Pharmaceuticals Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Lupin Pharmaceuticals Cephalosporin Products and Services
11.4.5 Lupin Pharmaceuticals SWOT Analysis
11.4.6 Lupin Pharmaceuticals Recent Developments
11.5 Hospira
11.5.1 Hospira Corporation Information
11.5.2 Hospira Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Hospira Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Hospira Cephalosporin Products and Services
11.5.5 Hospira SWOT Analysis
11.5.6 Hospira Recent Developments
11.6 Dhanuka Laboratories
11.6.1 Dhanuka Laboratories Corporation Information
11.6.2 Dhanuka Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Dhanuka Laboratories Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Dhanuka Laboratories Cephalosporin Products and Services
11.6.5 Dhanuka Laboratories SWOT Analysis
11.6.6 Dhanuka Laboratories Recent Developments
11.7 Fukang
11.7.1 Fukang Corporation Information
11.7.2 Fukang Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Fukang Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Fukang Cephalosporin Products and Services
11.7.5 Fukang SWOT Analysis
11.7.6 Fukang Recent Developments
11.8 Dongying Pharmaceutical
11.8.1 Dongying Pharmaceutical Corporation Information
11.8.2 Dongying Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Dongying Pharmaceutical Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Dongying Pharmaceutical Cephalosporin Products and Services
11.8.5 Dongying Pharmaceutical SWOT Analysis
11.8.6 Dongying Pharmaceutical Recent Developments
11.9 Alkem
11.9.1 Alkem Corporation Information
11.9.2 Alkem Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Alkem Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Alkem Cephalosporin Products and Services
11.9.5 Alkem SWOT Analysis
11.9.6 Alkem Recent Developments
11.10 SALUBRIS
11.10.1 SALUBRIS Corporation Information
11.10.2 SALUBRIS Business Overview and Total Revenue (2019 VS 2018)
11.10.3 SALUBRIS Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 SALUBRIS Cephalosporin Products and Services
11.10.5 SALUBRIS SWOT Analysis
11.10.6 SALUBRIS Recent Developments
11.11 LIVZON
11.11.1 LIVZON Corporation Information
11.11.2 LIVZON Business Overview and Total Revenue (2019 VS 2018)
11.11.3 LIVZON Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 LIVZON Cephalosporin Products and Services
11.11.5 LIVZON SWOT Analysis
11.11.6 LIVZON Recent Developments
11.12 Hetero Drugs
11.12.1 Hetero Drugs Corporation Information
11.12.2 Hetero Drugs Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Hetero Drugs Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Hetero Drugs Cephalosporin Products and Services
11.12.5 Hetero Drugs SWOT Analysis
11.12.6 Hetero Drugs Recent Developments
11.13 CSPC
11.13.1 CSPC Corporation Information
11.13.2 CSPC Business Overview and Total Revenue (2019 VS 2018)
11.13.3 CSPC Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 CSPC Cephalosporin Products and Services
11.13.5 CSPC SWOT Analysis
11.13.6 CSPC Recent Developments
11.14 TEVA
11.14.1 TEVA Corporation Information
11.14.2 TEVA Business Overview and Total Revenue (2019 VS 2018)
11.14.3 TEVA Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.14.4 TEVA Cephalosporin Products and Services
11.14.5 TEVA SWOT Analysis
11.14.6 TEVA Recent Developments
11.15 Orchid Pharma
11.15.1 Orchid Pharma Corporation Information
11.15.2 Orchid Pharma Business Overview and Total Revenue (2019 VS 2018)
11.15.3 Orchid Pharma Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.15.4 Orchid Pharma Cephalosporin Products and Services
11.15.5 Orchid Pharma SWOT Analysis
11.15.6 Orchid Pharma Recent Developments
11.16 Taj Pharmaceuticals
11.16.1 Taj Pharmaceuticals Corporation Information
11.16.2 Taj Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.16.3 Taj Pharmaceuticals Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.16.4 Taj Pharmaceuticals Cephalosporin Products and Services
11.16.5 Taj Pharmaceuticals SWOT Analysis
11.16.6 Taj Pharmaceuticals Recent Developments
11.17 Covalent Laboratories
11.17.1 Covalent Laboratories Corporation Information
11.17.2 Covalent Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.17.3 Covalent Laboratories Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.17.4 Covalent Laboratories Cephalosporin Products and Services
11.17.5 Covalent Laboratories SWOT Analysis
11.17.6 Covalent Laboratories Recent Developments
11.18 United Laboratories
11.18.1 United Laboratories Corporation Information
11.18.2 United Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.18.3 United Laboratories Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.18.4 United Laboratories Cephalosporin Products and Services
11.18.5 United Laboratories SWOT Analysis
11.18.6 United Laboratories Recent Developments
11.19 Aurobindo
11.19.1 Aurobindo Corporation Information
11.19.2 Aurobindo Business Overview and Total Revenue (2019 VS 2018)
11.19.3 Aurobindo Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.19.4 Aurobindo Cephalosporin Products and Services
11.19.5 Aurobindo SWOT Analysis
11.19.6 Aurobindo Recent Developments
11.20 Wockhardt
11.20.1 Wockhardt Corporation Information
11.20.2 Wockhardt Business Overview and Total Revenue (2019 VS 2018)
11.20.3 Wockhardt Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.20.4 Wockhardt Cephalosporin Products and Services
11.20.5 Wockhardt SWOT Analysis
11.20.6 Wockhardt Recent Developments
11.21 LKPC
11.21.1 LKPC Corporation Information
11.21.2 LKPC Business Overview and Total Revenue (2019 VS 2018)
11.21.3 LKPC Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.21.4 LKPC Cephalosporin Products and Services
11.21.5 LKPC SWOT Analysis
11.21.6 LKPC Recent Developments
11.22 HPGC
11.22.1 HPGC Corporation Information
11.22.2 HPGC Business Overview and Total Revenue (2019 VS 2018)
11.22.3 HPGC Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.22.4 HPGC Cephalosporin Products and Services
11.22.5 HPGC SWOT Analysis
11.22.6 HPGC Recent Developments
11.23 Huafangpharm
11.23.1 Huafangpharm Corporation Information
11.23.2 Huafangpharm Business Overview and Total Revenue (2019 VS 2018)
11.23.3 Huafangpharm Cephalosporin Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.23.4 Huafangpharm Cephalosporin Products and Services
11.23.5 Huafangpharm SWOT Analysis
11.23.6 Huafangpharm Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Cephalosporin Sales Channels
12.2.2 Cephalosporin Distributors
12.3 Cephalosporin Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Cephalosporin Sales Forecast (2021-2026)
13.1.1 Global Cephalosporin Sales Forecast by Regions (2021-2026)
13.1.2 Global Cephalosporin Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Cephalosporin Sales Forecast (2021-2026)
13.2.2 North America Cephalosporin Revenue Forecast (2021-2026)
13.2.3 North America Cephalosporin Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Cephalosporin Sales Forecast (2021-2026)
13.3.2 Europe Cephalosporin Revenue Forecast (2021-2026)
13.3.3 Europe Cephalosporin Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Cephalosporin Sales Forecast (2021-2026)
13.4.2 Asia Pacific Cephalosporin Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Cephalosporin Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Cephalosporin Sales Forecast (2021-2026)
13.5.2 Latin America Cephalosporin Revenue Forecast (2021-2026)
13.5.3 Latin America Cephalosporin Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Cephalosporin Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Cephalosporin Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Cephalosporin Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Cephalosporin Key Market Segments
Table 2. Ranking of Global Top Cephalosporin Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Cephalosporin Market Size Growth Rate by Type 2021-2026 (MT) & (Million US$)
Table 4. Major Manufacturers of First Generation
Table 5. Major Manufacturers of Second Generation
Table 6. Major Manufacturers of Third Generation
Table 7. Major Manufacturers of Fourth Generation
Table 8. Global Cephalosporin Market Share by Application 2019-2025 (MT)
Table 9. Global Cephalosporin Market Size by Regions 2015-2020 (MT) & (Million US$)
Table 10. Global Cephalosporin Sales by Regions 2015-2020 (MT)
Table 11. Global Cephalosporin Sales Market Share by Regions 2015-2020
Table 12. Global Cephalosporin Revenue by Regions 2015-2020 (Million US$)
Table 13. Global Cephalosporin Revenue Market Share by Regions 2015-2020
Table 14. Top Cephalosporin Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 15. Market Top Trends
Table 16. Cephalosporin Key Drivers: Impact Analysis (2021-2026)
Table 17. Cephalosporin Key Challenges
Table 18. Main Points Interviewed from Key Cephalosporin Players: Views for Future
Table 19. Global Cephalosporin Sales by Manufacturers (2015-2020) (MT)
Table 20. Global Cephalosporin Sales Share by Manufacturers (2015-2020)
Table 21. Cephalosporin Revenue by Manufacturers (2015-2020) (Million US$)
Table 22. Cephalosporin Revenue Share by Manufacturers (2015-2020)
Table 23. Global Cephalosporin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cephalosporin as of 2019)
Table 25. Key Manufacturers Cephalosporin Average Selling Price (ASP) (2015-2020) (USD/Kg)
Table 26. Key Manufacturers Cephalosporin Plants/Factories Distribution
Table 27. Key Manufacturers Cephalosporin Area Served
Table 28. Date of Key Manufacturers Enter into Cephalosporin Market
Table 29. Key Manufacturers Cephalosporin Product Type
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global First Generation Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 32. Global Second Generation Sales and Revenue (2015-2020) (MT) & (Million US$)
Table 33. Global Third Generation Sales ana Revenue (2015-2020) (MT) & (Million US$)
Table 34. Global Fourth Generation Sales ana Revenue (2015-2020) (MT) & (Million US$)
Table 35. Global Cephalosporin Sales (MT) by Type (2015-2020)
Table 36. Global Cephalosporin Sales Share by Type (2015-2020)
Table 37. Global Cephalosporin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 38. Global Cephalosporin Price (MT) by Type (2015-2020)
Table 39. Global Cephalosporin Sales (MT) by Type (2021-2026)
Table 40. Global Cephalosporin Sales Share by Type (2021-2026)
Table 41. Global Cephalosporin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 42. Global Cephalosporin Revenue Share by Type (2021-2026)
Table 43. Global Cephalosporin Price (MT) by Type (2021-2026)
Table 44. Global Cephalosporin Sales (MT) by Application (2015-2020)
Table 45. Global Cephalosporin Sales Share by Application (2015-2020)
Table 46. Global Cephalosporin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 47. Global Cephalosporin Price by Application 2015-2020 (USD/Kg)
Table 48. Global Cephalosporin Sales by Application (2015-2020) (MT)
Table 49. Global Cephalosporin Sales Share by Application (2015-2020)
Table 50. Global Cephalosporin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 51. Global Cephalosporin Revenue Share by Application (2021-2026)
Table 52. Global Cephalosporin Price (MT) by Application (2021-2026)
Table 53. North America Cephalosporin Sales by Company (2015-2020) (MT)
Table 54. North America Cephalosporin Sales Market Share by Company (2015-2020)
Table 55. North America Cephalosporin Sales by Type (2015-2020) (MT)
Table 56. North America Cephalosporin Sales Market Share by Type (2015-2020)
Table 57. North America Cephalosporin Sales by Application (2015-2020) (MT)
Table 58. North America Cephalosporin Sales Market Share by Application (2015-2020)
Table 59. North America Cephalosporin Sales by Countries (2015-2020) (MT)
Table 60. North America Cephalosporin Sales Market Share by Countries (2015-2020)
Table 61. North America Cephalosporin Revenue by Countries (2015-2020) (Million US$)
Table 62. North America Cephalosporin Revenue Market Share by Countries (2015-2020)
Table 63. Europe Cephalosporin Sales by Company (2015-2020) (MT)
Table 64. Europe Cephalosporin Sales Market Share by Company (2015-2020)
Table 65. Europe Cephalosporin Sales by Type (2015-2020) (MT)
Table 66. Europe Cephalosporin Sales Market Share by Type (2015-2020)
Table 67. Europe Cephalosporin Sales by Application (2015-2020) (MT)
Table 68. Europe Cephalosporin Sales Market Share by Application (2015-2020)
Table 69. Europe Cephalosporin Sales by Countries (2015-2020) (MT)
Table 70. Europe Cephalosporin Sales Market Share by Countries (2015-2020)
Table 71. Europe Cephalosporin Revenue by Countries (2015-2020) (Million US$)
Table 72. Europe Cephalosporin Revenue Market Share by Countries (2015-2020)
Table 73. Asia Pacific Cephalosporin Sales by Regions (2015-2020) (MT)
Table 74. Asia Pacific Cephalosporin Sales Market Share by Regions (2015-2020)
Table 75. Asia Pacific Cephalosporin Sales by Type (2015-2020) (MT)
Table 76. Asia Pacific Cephalosporin Sales Market Share by Type (2015-2020)
Table 77. Asia Pacific Cephalosporin Sales by Application (2015-2020) (MT)
Table 78. Asia Pacific Cephalosporin Sales Market Share by Application (2015-2020)
Table 79. Asia Pacific Cephalosporin Sales by Countries (2015-2020) (MT)
Table 80. Asia Pacific Cephalosporin Sales Market Share by Regions (2015-2020)
Table 81. Asia Pacific Cephalosporin Revenue by Regions (2015-2020) (Million US$)
Table 82. Asia Pacific Cephalosporin Revenue Market Share by Regions (2015-2020)
Table 83. Latin America Cephalosporin Sales by Company (2015-2020) (MT)
Table 84. Latin America Cephalosporin Sales Market Share by Company (2015-2020)
Table 85. Latin America Cephalosporin Sales by Type (2015-2020) (MT)
Table 86. Latin America Cephalosporin Sales Market Share by Type (2015-2020)
Table 87. Latin America Cephalosporin Sales by Application (2015-2020) (MT)
Table 88. Latin America Cephalosporin Sales Market Share by Application (2015-2020)
Table 89. Latin America Cephalosporin Sales by Countries (2015-2020) (MT)
Table 90. Latin America Cephalosporin Sales Market Share by Countries (2015-2020)
Table 91. Latin America Cephalosporin Revenue by Countries (2015-2020) (Million US$)
Table 92. Latin America Cephalosporin Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Cephalosporin Sales by Type (2015-2020) (MT)
Table 94. Middle East and Africa Cephalosporin Sales Market Share by Type (2015-2020)
Table 95. Middle East and Africa Cephalosporin Sales by Application (2015-2020) (MT)
Table 96. Middle East and Africa Cephalosporin Sales Market Share by Application (2015-2020)
Table 97. Middle East and Africa Cephalosporin Sales by Countries (2015-2020) (MT)
Table 98. Middle East and Africa Cephalosporin Sales Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Cephalosporin Revenue by Countries (2015-2020) (Million US$)
Table 100. Middle East and Africa Cephalosporin Revenue Market Share by Countries (2015-2020)
Table 101. Union Chempharma Company Details
Table 102. Union Chempharma Description and Business Overview
Table 103. Union Chempharma Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Union Chempharma Cephalosporin Sales Growth Rate (2015-2020)
Table 105. Union Chempharma Cephalosporin Sales Market Share in Global Market
Table 106. Union Chempharma Recent Development
Table 107. NCPC Company Details
Table 108. NCPC Description and Business Overview
Table 109. NCPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 110. NCPC Cephalosporin Sales Growth Rate (2015-2020)
Table 111. NCPC Cephalosporin Sales Market Share in Global Market
Table 112. NCPC Recent Development
Table 113. Qilu Antibiotics Company Details
Table 114. Qilu Antibiotics Description and Business Overview
Table 115. Qilu Antibiotics Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 116. Qilu Antibiotics Cephalosporin Sales Growth Rate (2015-2020)
Table 117. Qilu Antibiotics Cephalosporin Sales Market Share in Global Market
Table 118. Qilu Antibiotics Recent Development
Table 119. Lupin Pharmaceuticals Company Details
Table 120. Lupin Pharmaceuticals Description and Business Overview
Table 121. Lupin Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Lupin Pharmaceuticals Cephalosporin Sales Growth Rate (2015-2020)
Table 123. Lupin Pharmaceuticals Cephalosporin Sales Market Share in Global Market
Table 124. Lupin Pharmaceuticals Recent Development
Table 125. Hospira Company Details
Table 126. Hospira Description and Business Overview
Table 127. Hospira Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Hospira Cephalosporin Sales Growth Rate (2015-2020)
Table 129. Hospira Cephalosporin Sales Market Share in Global Market
Table 130. Hospira Recent Development
Table 131. Dhanuka Laboratories Company Details
Table 132. Dhanuka Laboratories Description and Business Overview
Table 133. Dhanuka Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 134. Dhanuka Laboratories Cephalosporin Sales Growth Rate (2015-2020)
Table 135. Dhanuka Laboratories Cephalosporin Sales Market Share in Global Market
Table 136. Dhanuka Laboratories Recent Development
Table 137. Fukang Company Details
Table 138. Fukang Description and Business Overview
Table 139. Fukang Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 140. Fukang Cephalosporin Sales Growth Rate (2015-2020)
Table 141. Fukang Cephalosporin Sales Market Share in Global Market
Table 142. Fukang Recent Development
Table 143. Dongying Pharmaceutical Company Details
Table 144. Dongying Pharmaceutical Description and Business Overview
Table 145. Dongying Pharmaceutical Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 146. Dongying Pharmaceutical Cephalosporin Sales Growth Rate (2015-2020)
Table 147. Dongying Pharmaceutical Cephalosporin Sales Market Share in Global Market
Table 148. Dongying Pharmaceutical Recent Development
Table 149. Alkem Company Details
Table 150. Alkem Description and Business Overview
Table 151. Alkem Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 152. Alkem Cephalosporin Sales Growth Rate (2015-2020)
Table 153. Alkem Cephalosporin Sales Market Share in Global Market
Table 154. Alkem Recent Development
Table 155. SALUBRIS Company Details
Table 156. SALUBRIS Description and Business Overview
Table 157. SALUBRIS Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 158. SALUBRIS Cephalosporin Sales Growth Rate (2015-2020)
Table 159. SALUBRIS Cephalosporin Sales Market Share in Global Market
Table 160. SALUBRIS Recent Development
Table 161. LIVZON Company Details
Table 162. LIVZON Description and Business Overview
Table 163. LIVZON Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 164. LIVZON Cephalosporin Sales Growth Rate (2015-2020)
Table 165. LIVZON Cephalosporin Sales Market Share in Global Market
Table 166. LIVZON Recent Development
Table 167. Hetero Drugs Company Details
Table 168. Hetero Drugs Description and Business Overview
Table 169. Hetero Drugs Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 170. Hetero Drugs Cephalosporin Sales Growth Rate (2015-2020)
Table 171. Hetero Drugs Cephalosporin Sales Market Share in Global Market
Table 172. Hetero Drugs Recent Development
Table 173. CSPC Company Details
Table 174. CSPC Description and Business Overview
Table 175. CSPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 176. CSPC Cephalosporin Sales Growth Rate (2015-2020)
Table 177. CSPC Cephalosporin Sales Market Share in Global Market
Table 178. CSPC Recent Development
Table 179. TEVA Company Details
Table 180. TEVA Description and Business Overview
Table 181. TEVA Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 182. TEVA Cephalosporin Sales Growth Rate (2015-2020)
Table 183. TEVA Cephalosporin Sales Market Share in Global Market
Table 184. TEVA Recent Development
Table 185. Orchid Pharma Company Details
Table 186. Orchid Pharma Description and Business Overview
Table 187. Orchid Pharma Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 188. Orchid Pharma Cephalosporin Sales Growth Rate (2015-2020)
Table 189. Orchid Pharma Cephalosporin Sales Market Share in Global Market
Table 190. Orchid Pharma Recent Development
Table 191. Taj Pharmaceuticals Company Details
Table 192. Taj Pharmaceuticals Description and Business Overview
Table 193. Taj Pharmaceuticals Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 194. Taj Pharmaceuticals Cephalosporin Sales Growth Rate (2015-2020)
Table 195. Taj Pharmaceuticals Cephalosporin Sales Market Share in Global Market
Table 196. Taj Pharmaceuticals Recent Development
Table 197. Covalent Laboratories Company Details
Table 198. Covalent Laboratories Description and Business Overview
Table 199. Covalent Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 200. Covalent Laboratories Cephalosporin Sales Growth Rate (2015-2020)
Table 201. Covalent Laboratories Cephalosporin Sales Market Share in Global Market
Table 202. Covalent Laboratories Recent Development
Table 203. United Laboratories Company Details
Table 204. United Laboratories Description and Business Overview
Table 205. United Laboratories Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 206. United Laboratories Cephalosporin Sales Growth Rate (2015-2020)
Table 207. United Laboratories Cephalosporin Sales Market Share in Global Market
Table 208. United Laboratories Recent Development
Table 209. Aurobindo Company Details
Table 210. Aurobindo Description and Business Overview
Table 211. Aurobindo Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 212. Aurobindo Cephalosporin Sales Growth Rate (2015-2020)
Table 213. Aurobindo Cephalosporin Sales Market Share in Global Market
Table 214. Aurobindo Recent Development
Table 215. Wockhardt Company Details
Table 216. Wockhardt Description and Business Overview
Table 217. Wockhardt Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 218. Wockhardt Cephalosporin Sales Growth Rate (2015-2020)
Table 219. Wockhardt Cephalosporin Sales Market Share in Global Market
Table 220. Wockhardt Recent Development
Table 221. LKPC Company Details
Table 222. LKPC Description and Business Overview
Table 223. LKPC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 224. LKPC Cephalosporin Sales Growth Rate (2015-2020)
Table 225. LKPC Cephalosporin Sales Market Share in Global Market
Table 226. LKPC Recent Development
Table 227. HPGC Company Details
Table 228. HPGC Description and Business Overview
Table 229. HPGC Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 230. HPGC Cephalosporin Sales Growth Rate (2015-2020)
Table 231. HPGC Cephalosporin Sales Market Share in Global Market
Table 232. HPGC Recent Development
Table 233. Huafangpharm Company Details
Table 234. Huafangpharm Description and Business Overview
Table 235. Huafangpharm Cephalosporin Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020)
Table 236. Huafangpharm Cephalosporin Sales Growth Rate (2015-2020)
Table 237. Huafangpharm Cephalosporin Sales Market Share in Global Market
Table 238. Huafangpharm Recent Development
Table 239. Cephalosporin Distributors List
Table 240. Cephalosporin Customers List
Table 241. Global Cephalosporin Sales Forecast 2021-2026 (MT) & (Million US$)
Table 242. Global Cephalosporin Sales Forecast by Type 2021-2026 (MT)
Table 243. Global Cephalosporin Sales Forecast by Application 2021-2026 (MT)
Table 244. Global Cephalosporin Sales Forecast by Regions 2021-2026 (MT)
Table 245. Global Cephalosporin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 246. North America Cephalosporin Sales Forecast by Countries 2021-2026 (MT)
Table 247. North America Cephalosporin Revenue Forecast by Countries 2021-2026
Table 248. Europe Cephalosporin Sales Forecast by Countries 2021-2026 (MT)
Table 249. Europe Cephalosporin Revenue Market Share Forecast by Countries 2021-2026
Table 250. Asia Pacific Cephalosporin Sales Forecast by Regions 2021-2026 (MT)
Table 251. Asia Pacific Cephalosporin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 252. Latin America Cephalosporin Sales Forecast by Countries 2021-2026 (MT)
Table 253. Latin America Cephalosporin Revenue Forecast by Countries 2021-2026 (Million US$)
Table 254. Middle East and Africa Cephalosporin Sales Forecast by Regions 2021-2026 (MT)
Table 255. Middle East and Africa Cephalosporin Revenue Forecast by Regions 2021-2026 (Million US$)
Table 256. Research Programs/Design for This Report
Table 257. Key Data Information from Secondary Sources
Table 258. Key Data Information from Primary Sources
List of Figures
Figure 1. Cephalosporin Product Picture
Figure 2. Global Cephalosporin Sales Market Shar by Type 2015-2026
Figure 3. First Generation Figures
Figure 4. Second Generation Figures
Figure 5. Third Generation Figures
Figure 6. Fourth Generation Figures
Figure 7. Global Cephalosporin Sales Market Share by Application in 2019 & 2026
Figure 8. Oral Use Case
Figure 9. Injection Use Case
Figure 10. Cephalosporin Report Years Considered
Figure 11. Global Cephalosporin Market Size 2015-2026 (Million US$)
Figure 12. Global Cephalosporin Sales 2015-2020 (MT)
Figure 13. Global Cephalosporin Market Size Market Share by Regions 2015-2020
Figure 14. Global Cephalosporin Sales Market Share by Regions in 2019
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Cephalosporin Sales Share by Manufacturers in 2019
Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Cephalosporin Sales in 2019
Figure 18. Cephalosporin Value Share by Manufacturers in 2019
Figure 19. Cephalosporin Revenue Share by Manufacturers In 2019
Figure 20. Cephalosporin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Cephalosporin Revenue Share by Type (2015-2020)
Figure 22. Global Cephalosporin Revenue Growth Rate by Type in 2015 & 2019
Figure 23. Global Cephalosporin Market Share by Price Range (2015-2020)
Figure 24. Global Cephalosporin Revenue Share by Application (2015-2020)
Figure 25. Global Cephalosporin Revenue Growth Rate by Application in 2015 & 2019
Figure 26. North America Cephalosporin Revenue Growth Rate 2015-2020 (Million US$)
Figure 27. U.S. Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 28. Canada Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 29. Europe Cephalosporin Revenue Growth Rate 2015-2020 (Million US$)
Figure 30. Germany Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 31. France Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 32. U.K. Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 33. Italy Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 34. Russia Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 35. Asia Pacific Cephalosporin Revenue Growth Rate 2015-2020 (Million US$)
Figure 36. China Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 37. Japan Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 38. South Korea Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 39. India Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 40. Australia Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 41. Taiwan Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 42. Indonesia Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 43. Thailand Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 44. Malaysia Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 45. Philippines Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 46. Vietnam Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 47. Latin America Cephalosporin Revenue Growth Rate 2015-2020 (Million US$)
Figure 48. Mexico Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 49. Brazil Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 50. Argentina Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 51. Middle East and Africa Cephalosporin Revenue Growth Rate 2015-2020 (Million US$)
Figure 52. Turkey Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 53. Saudi Arabia Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 54. U.A.E Cephalosporin Sales Growth Rate (2015-2020) (MT)
Figure 55. Union Chempharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. NCPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Qilu Antibiotics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hospira Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Dhanuka Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Fukang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Dongying Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Alkem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. SALUBRIS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. LIVZON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Hetero Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. CSPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Orchid Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Taj Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Covalent Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 72. United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 73. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 74. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 75. LKPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 76. HPGC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Huafangpharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Cephalosporin Value Chain
Figure 79. Channels of Distribution
Figure 80. Distributors Profiles
Figure 81. North America Cephalosporin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 82. North America Cephalosporin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 83. Europe Cephalosporin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 84. Europe Cephalosporin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 85. Asia Pacific Cephalosporin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 86. Asia Pacific Cephalosporin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 87. Latin America Cephalosporin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 88. Latin America Cephalosporin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 89. Middle East and Africa Cephalosporin Sales Growth Rate Forecast (2021-2026) (MT)
Figure 90. Middle East and Africa Cephalosporin Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


【掲載企業】

Union Chempharma、NCPC、Qilu Antibiotics、Lupin Pharmaceuticals、Hospira、Dhanuka Laboratories、Fukang、Dongying Pharmaceutical、Alkem、SALUBRIS、LIVZON、Hetero Drugs、CSPC、TEVA、Orchid Pharma、Taj Pharmaceuticals、Covalent Laboratories、United Laboratories、Aurobindo、Wockhardt、LKPC、HPGC、Huafangpharm

★調査レポート[世界のセファロスポリン市場:成長動向・競争分析2020-2026] (コード:QYR20AP00506)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のセファロスポリン市場:成長動向・競争分析2020-2026]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆